Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
Open Access
- 26 July 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 14 (10), 2773-2779
- https://doi.org/10.1245/s10434-007-9396-6
Abstract
Background We studied the maximum tolerated dose (MTD) and efficacy of oxaliplatin added to capecitabine and radiotherapy (Capox-RT) as neoadjuvant therapy for rectal cancer. Methods T3-4 rectal cancer patients received escalating doses of oxaliplatin (day 1 and 29) with a fixed dose of capecitabine of 1000 mg/m2 twice daily (days 1–14, 25–38) added to RT with 50.4 Gy and surgery after 6–8 weeks. The MTD, determined during phase I, was used in the subsequent phase II, in which R0 resection rate (a negative circumferential resection margin) was the primary end point. Results Twenty-one patients were evaluable. In the phase I part, oxaliplatin at 85 mg/m2 was established as MTD. In phase II, the main toxicity was grade III diarrhea (18%). All patients underwent surgery, and 20 patients had a resectable tumor. An R0 was achieved in 17/21 patients, downstaging to T0-2 in 7/21 and a pCR in 2/21. Conclusion Combination of Capox-RT has an acceptable acute toxicity profile and a high R0 resection rate of 81% in locally advanced rectal cancer. However the pCR rate was low.Keywords
This publication has 35 references indexed in Scilit:
- Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Journal of Clinical Oncology, 2006
- Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5‐fluorouracilJournal of Surgical Oncology, 2006
- New options and old dilemmas in the treatment of patients with advanced colorectal cancerAnnals of Oncology, 2004
- Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiotherapy and Oncology, 2004
- Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance: Report of the 22921 randomised trial conducted by the EORTC Radiotherapy GroupEuropean Journal of Cancer, 2004
- Oxaliplatin–5-Fluorouracil and Ionizing RadiationOncology, 2003
- Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal CancerJournal of Clinical Oncology, 2002
- Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west NetherlandsEuropean Journal of Surgical Oncology, 1998
- Effect of the introduction of total mesorectal excision for the treatment of rectal cancerBritish Journal of Surgery, 1998
- Measuring the quality of life of cancer patients: A concise QL-Index for use by physiciansJournal of Chronic Diseases, 1981